Camp4 Therapeutics Corp
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
CAMP | NDAQ
Overview
Corporate Details
- ISIN(s):
- US13463J1016
- LEI:
- Country:
- United States of America
- Address:
- ONE KENDALL SQUARE, 2139 CAMBRIDGE
- Website:
- https://www.camp4tx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Camp4 Therapeutics Corp. is a clinical-stage biopharmaceutical company pioneering a novel approach to programmable therapeutics. The company develops RNA-based treatments by leveraging its proprietary Regulatory RNA Actuator Platform (RAP Platform™). This platform is designed to discover and create RNA Actuators, a class of antisense oligonucleotide (ASO) therapies that selectively target and upregulate the expression of specific genes. By increasing the output of essential proteins, Camp4 aims to address the root cause of genetic diseases. The company's therapeutic pipeline is initially focused on developing treatments for rare metabolic and central nervous system (CNS) disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Camp4 Therapeutics Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Camp4 Therapeutics Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Camp4 Therapeutics Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
